Saqlain Haider1, Manal Alhusban2, Narayan D Chaurasiya1, Babu L Tekwani1, Amar G Chittiboyina1, Ikhlas A Khan1. 1. National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, MS 38677, USA. 2. Division of Pharmacognosy, Division of Pharmacology, Department of BioMolecular Sciences, School of Pharmacy, The University of Mississippi, MS 38677, USA.
Abstract
AIM: There is little information available on the monoamine oxidase isoform selectivity of N-alkyl harmine analogs, which exhibit a myriad of activities including MAO-A, DYRK1A and cytotoxicity to several select cancer cell lines. RESULTS: Compounds 3e and 4c exhibited an IC50 of 0.83 ± 0.03 and 0.43 ± 0.002 μM against MAO-A and an IC50 of 0.26 ± 0.04 and 0.36 ± 0.001 μM against MAO-B, respectively. Molecular docking studies revealed π-π interactions between the synthesized molecules and aromatic amino acid residues. Conclusion & future perspective: The current study delineates the structural requirements for MAO-A selectivity and such information may be helpful in designing selective analogs for kinase, DYRK1A and harmine-based cytotoxics without apparent MAO enzyme inhibition.
AIM: There is little information available on the monoamine oxidase isoform selectivity of N-alkyl harmine analogs, which exhibit a myriad of activities including MAO-A, DYRK1A and cytotoxicity to several select cancer cell lines. RESULTS: Compounds 3e and 4c exhibited an IC50 of 0.83 ± 0.03 and 0.43 ± 0.002 μM against MAO-A and an IC50 of 0.26 ± 0.04 and 0.36 ± 0.001 μM against MAO-B, respectively. Molecular docking studies revealed π-π interactions between the synthesized molecules and aromatic amino acid residues. Conclusion & future perspective: The current study delineates the structural requirements for MAO-A selectivity and such information may be helpful in designing selective analogs for kinase, DYRK1A and harmine-based cytotoxics without apparent MAO enzyme inhibition.
Authors: Binia Drung; Christoph Scholz; Valéria A Barbosa; Azadeh Nazari; Maria H Sarragiotto; Boris Schmidt Journal: Bioorg Med Chem Lett Date: 2014-09-02 Impact factor: 2.823
Authors: A W Bach; N C Lan; D L Johnson; C W Abell; M E Bembenek; S W Kwan; P H Seeburg; J C Shih Journal: Proc Natl Acad Sci U S A Date: 1988-07 Impact factor: 11.205
Authors: Narayan D Chaurasiya; Mohamed A Ibrahim; Ilias Muhammad; Larry A Walker; Babu L Tekwani Journal: Molecules Date: 2014-11-18 Impact factor: 4.411
Authors: Michael Tarpley; Helen O Oladapo; Dillon Strepay; Thomas B Caligan; Lhoucine Chdid; Hassan Shehata; Jose R Roques; Rhashad Thomas; Christopher P Laudeman; Rob U Onyenwoke; David B Darr; Kevin P Williams Journal: Eur J Pharm Sci Date: 2021-03-27 Impact factor: 5.112
Authors: Narayan D Chaurasiya; Jacob Midiwo; Pankaj Pandey; Regina N Bwire; Robert J Doerksen; Ilias Muhammad; Babu L Tekwani Journal: Molecules Date: 2020-11-17 Impact factor: 4.411